CONMED Corporation CNMD
At closeNov 6, 2026, 4:00 PM EST
After hours · Nov 6, 4:00 PM ET
- YTD
- +26.85%
- 1 year
- +16.49%
- Market cap
- 1.53B
- Revenue (ttm)
- 1.37B
- Profit margin
- 5.36%
- EPS (ttm)
- 2.41
- Shares out
- 29.80M
- P/E ratio
- 21.37
- Forward P/E
- 10.85
- Dividend
- 0.80
- Ex-dividend date
- Sep 14, 2025
- YTD return
- +26.85%
- 1-year return
- +16.49%
- Volume
- 331.56K
- Avg volume
- 368.51K
- Open
- 51.11
- Previous close
- 52.83
- Day's range
- 51.31 – 52.39
- 52-week range
- 32.11 – 53.66
- Beta
- 0.90
- Analysts
- Hold
- Price target
- 46.83 (-9.1%)
- Earnings date
- Jan 27, 2027
5D +6.56 (+14.60%)
Key statistics
- Enterprise value
- 2.34B
- PEG ratio
- 1.84
- Price / sales
- 1.12
- Price / book
- 1.45
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -0.70%
- Free cash flow
- 107.01M
- Total cash
- 47.97M
- Total debt
- 815.87M
- Return on equity
- 7.10%
- Short % of float
- 7.61%
- 50-day average
- 47.00
- 200-day average
- 41.57
Analyst view
Consensus: hold
- Target (low)
- 43.00
- Target (mean)
- 46.83
- Target (high)
- 50.00
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell1
Next earnings
Jan 27, 2027
Expected Jan 27, 2027. Consensus EPS estimate 1.26.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 27, 2027 | Dec 30, 2026 | 1.27 | — | — | — |
| Oct 28, 2026 | Sep 30, 2026 | 1.00 | 1.04 | +0.04 | +4.00% |
| Jul 29, 2026 | Jun 30, 2026 | 1.11 | 1.38 | +0.27 | +24.32% |
| Apr 29, 2026 | Mar 31, 2026 | 0.82 | 0.89 | +0.07 | +8.54% |
| Jan 28, 2026 | Dec 31, 2025 | 1.32 | 1.43 | +0.11 | +8.33% |
| Nov 5, 2025 | Sep 30, 2025 | 1.05 | 1.08 | +0.03 | +2.86% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | JP Morgan | main | Neutral | Neutral |
| Oct 29, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | Piper Sandler | reit | Neutral | Neutral |
| Jul 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Jul 9, 2026 | BMO Capital | init | — | Market Perform |
| Jun 29, 2026 | B of A Securities | down | Neutral | Underperform |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solutions comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures; and products to treat diseases of dilation, hemostasis, biliary, stricture management, and infection prevention, as well as ECG electrodes, EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- conmed.com
News
CONMED Corporation to Participate in the Jefferies Global Healthcare Conference 
JP Morgan Maintains Neutral on Conmed, Raises Price Target to $50 
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49 
Conmed Q3 2026 Earnings Call Transcript 
Conmed Raises FY2026 Adj EPS Guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 Est; Narrows FY2026 Sales Guidance from $1.358B-$1.373B to $1.360B-$1.366B vs $1.366B Est 
Conmed Q3 Adj. EPS $1.04 Beats $1.00 Estimate, Sales $335.557M Miss $336.226M Estimate - Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45
- Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
- Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est
CONMED Says AirSeal Robotic Solution Is Now Indicated For Use With Intuitive’s 8 mm Hex Cannulas Used As Part Of Intuitive Da Vinci 5 Platform
Your note
Sign in to keep a note on CNMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARONSON MARTHA GOLDBERG | Director | Conversion of Exercise of derivative security | Jun 2, 2025 | 14,391 |
| BRONSON DAVID M | Director | Conversion of Exercise of derivative security | Jun 1, 2026 | 17,909 |
| CONCANNON BRIAN P | Director | Conversion of Exercise of derivative security | Jun 2, 2025 | 10,116 |
| COUNCIL LAVERNE H. | Director | Conversion of Exercise of derivative security | Jun 1, 2026 | 4,716 |
| FARKAS CHARLES M | Director | Conversion of Exercise of derivative security | Jun 1, 2026 | 15,527 |
| FOUST HOLLIE K | General Counsel | Conversion of Exercise of derivative security | Nov 3, 2025 | 2,886 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.18% | 4,820,739 | 248.32M | Jun 29, 2026 |
| Earnest Partners LLC | 8.41% | 2,505,295 | 129.05M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.34% | 2,188,761 | 112.74M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 5.30% | 1,579,917 | 81.38M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 4.95% | 1,473,958 | 75.92M | Sep 29, 2026 |
| State Street Corporation | 4.76% | 1,417,468 | 73.01M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.98% | 1,782,274 | 91.80M | Sep 29, 2026 |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 4.43% | 1,319,068 | 67.95M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.21% | 958,140 | 49.35M | Jun 29, 2026 |
| SmallCap World Fund Inc | 2.69% | 801,295 | 41.27M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.68% | 799,401 | 41.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.31% | 689,876 | 35.54M | Jun 29, 2026 |